NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, reports financial results for the three and ninth months ended September 30, 2017 and provides a business update. “First off, we are significantly better positioned to support continued Avenova growth having entered into a $10.3 million financing with accredited investors